Compound Detail
CHEMBL3833321
LECANEMAB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL3833321 |
| Name | LECANEMAB |
| Phase | Approved |
| Structure Type | SEQ |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
7
Known Names
2
Indications
1
Mechanisms
Drug Information
| Molecule Type | Antibody |
| First Approval | 2023 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Amyloid-beta A4 protein inhibitor | INHIBITOR | Amyloid-beta precursor protein | ✓ | ✓ |
Indications
Alzheimer Disease Dementia
ATC Classification
N06DX04
lecanemab
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Drug Warnings
Black Box Warning
carcinogenicity
Data from ChEMBL 36 via Core Engine